Submissions received during the consultation period on the amendment to the Interim Guidance re: New Medicines

  1. AbbVie Corporation (PDF 218 KB)
  2. Alexion Pharma Canada (PDF 234 KB)
  3. Amgen Canada Inc. (PDF 410 KB)
  4. Association québécoise des pharmaciens propriétaires (AQPP) (PDF 871 KB)[available in French only]
  5. AstraZeneca Canada (PDF 253 KB)
  6. Bayer Inc. (PDF 166 KB)
  7. BIOQuébec (PDF 188 KB)[available in French only]
  8. BIOTECanada (PDF 164 KB)
  9. Boehringer Ingelheim (Canada) Ltd (PDF 183 KB)
  10. Bristol Myers Squibb Canada Co (PDF 97 KB)
  11. Canadian Association for Pharmacy Distribution Management (CAPDM) (PDF 239 KB)
  12. Canadian Breast Cancer Network (CBCN) (PDF 157 KB)
  13. Canadian Forum for Rare Disease Innovators (RAREi) (PDF 255 KB)
  14. Canadian Generic Pharmaceutical Association (CGPA) (PDF 142 KB)
  15. Canadian Life and Health Insurance Association (CLHIA) (PDF 598 KB)
  16. Canadian Organization for Rare Disorders (CORD) (PDF 919 KB)
  17. Cystic Fibrosis Canada (PDF 241 KB)
  18. Eisai Limited (PDF 192 KB)
  19. Eli Lilly Canada Inc. (PDF 222 KB)
  20. Elvium Life Sciences (PDF 140 KB)
  21. Fasken on behalf of the Constitutional Coalition (Merck, Boehringer Ingelheim, Janssen, Bayer, and Servier)[Submission not published at this time]
  22. Fédération des chambres de commerce du Québec (FCCQ) (PDF 251 KB)[available in French only]
  23. Gastrointestinal Society (PDF 224 KB)
  24. Gilead Sciences Canada Inc. (PDF 167 KB)
  25. Health Care enthusiast (PDF 2 KB)
  26. Hoffmann-La Roche Limited (PDF 77 KB)
  27. Incyte Biosciences Canada (PDF 226 KB)
  28. Innovative Medicines Canada (PDF 155 KB)
  29. Janssen Inc. (PDF 297 KB)
  30. LEO Pharma Canada (PDF 192 KB)
  31. Life Sciences Ontario (PDF 224 KB)
  32. Lundbeck Canada Inc. (PDF 199 KB)
  33. McKesson Canada (PDF 321 KB)
  34. Merck Canada Inc. (PDF 247 KB)
  35. Multiple Sclerosis Society of Canada (PDF 165 KB)
  36. Myeloma Canada (PDF 696 KB)
  37. Neighbourhood Pharmacy Association of Canada (PDF 215 KB)
  38. Novartis Pharmaceuticals Canada Inc. (PDF 114 KB)
  39. Novo Nordisk Canada Inc. (PDF 133 KB)
  40. PDCI Market Access (PDF 186 KB)
  41. Pfizer Canada (PDF 599 KB)
  42. Sanofi Canada (PDF 161 KB)
  43. Servier Canada Inc. (PDF 197 KB)
  44. Sumitomo Pharma Canada Inc. (PDF 149 KB)
  45. Takeda Canada Inc. (PDF 136 KB)

Page details

Date modified: